1099 related articles for article (PubMed ID: 30399156)
1. Predicting CD4 T-cell epitopes based on antigen cleavage, MHCII presentation, and TCR recognition.
Schneidman-Duhovny D; Khuri N; Dong GQ; Winter MB; Shifrut E; Friedman N; Craik CS; Pratt KP; Paz P; Aswad F; Sali A
PLoS One; 2018; 13(11):e0206654. PubMed ID: 30399156
[TBL] [Abstract][Full Text] [Related]
2. Determination of a Predictive Cleavage Motif for Eluted Major Histocompatibility Complex Class II Ligands.
Paul S; Karosiene E; Dhanda SK; Jurtz V; Edwards L; Nielsen M; Sette A; Peters B
Front Immunol; 2018; 9():1795. PubMed ID: 30127785
[TBL] [Abstract][Full Text] [Related]
3. Functional evidence for TCR-intrinsic specificity for MHCII.
Parrish HL; Deshpande NR; Vasic J; Kuhns MS
Proc Natl Acad Sci U S A; 2016 Mar; 113(11):3000-5. PubMed ID: 26831112
[TBL] [Abstract][Full Text] [Related]
4. Hunting down factor VIII in the immunopeptidome.
Hartholt RB; Peyron I; Voorberg J
Cell Immunol; 2016 Mar; 301():59-64. PubMed ID: 26610639
[TBL] [Abstract][Full Text] [Related]
5. Antigen identification for HLA class I- and HLA class II-restricted T cell receptors using cytokine-capturing antigen-presenting cells.
Lee MN; Meyerson M
Sci Immunol; 2021 Jan; 6(55):. PubMed ID: 33483338
[TBL] [Abstract][Full Text] [Related]
6. Construction and Screening of an Antigen-Derived Peptide Library Displayed on Yeast Cell Surface for CD4+ T Cell Epitope Identification.
Wen F; Smith MR; Zhao H
Methods Mol Biol; 2019; 2024():213-234. PubMed ID: 31364052
[TBL] [Abstract][Full Text] [Related]
7. Modified vaccinia virus Ankara-infected dendritic cells present CD4+ T-cell epitopes by endogenous major histocompatibility complex class II presentation pathways.
Thiele F; Tao S; Zhang Y; Muschaweckh A; Zollmann T; Protzer U; Abele R; Drexler I
J Virol; 2015 Mar; 89(5):2698-709. PubMed ID: 25520512
[TBL] [Abstract][Full Text] [Related]
8. Peptide linkage to the α-subunit of MHCII creates a stably inverted antigen presentation complex.
Schlundt A; Günther S; Sticht J; Wieczorek M; Roske Y; Heinemann U; Freund C
J Mol Biol; 2012 Oct; 423(3):294-302. PubMed ID: 22820093
[TBL] [Abstract][Full Text] [Related]
9. CD4+ T-cell epitope prediction using antigen processing constraints.
Mettu RR; Charles T; Landry SJ
J Immunol Methods; 2016 May; 432():72-81. PubMed ID: 26891811
[TBL] [Abstract][Full Text] [Related]
10. Enhancement to the RANKPEP resource for the prediction of peptide binding to MHC molecules using profiles.
Reche PA; Glutting JP; Zhang H; Reinherz EL
Immunogenetics; 2004 Sep; 56(6):405-19. PubMed ID: 15349703
[TBL] [Abstract][Full Text] [Related]
11. Recognition of Multiple Hybrid Insulin Peptides by a Single Highly Diabetogenic T-Cell Receptor.
Parras D; Solé P; Delong T; Santamaría P; Serra P
Front Immunol; 2021; 12():737428. PubMed ID: 34527002
[TBL] [Abstract][Full Text] [Related]
12. Quantification of HLA-DM-Dependent Major Histocompatibility Complex of Class II Immunopeptidomes by the Peptide Landscape Antigenic Epitope Alignment Utility.
Álvaro-Benito M; Morrison E; Abualrous ET; Kuropka B; Freund C
Front Immunol; 2018; 9():872. PubMed ID: 29774024
[TBL] [Abstract][Full Text] [Related]
13. Functional TCR retrieval from single antigen-specific human T cells reveals multiple novel epitopes.
Simon P; Omokoko TA; Breitkreuz A; Hebich L; Kreiter S; Attig S; Konur A; Britten CM; Paret C; Dhaene K; Türeci Ö; Sahin U
Cancer Immunol Res; 2014 Dec; 2(12):1230-44. PubMed ID: 25245536
[TBL] [Abstract][Full Text] [Related]
14. Sequence conservation analysis and in silico human leukocyte antigen-peptide binding predictions for the Mtb72F and M72 tuberculosis candidate vaccine antigens.
Mortier MC; Jongert E; Mettens P; Ruelle JL
BMC Immunol; 2015 Oct; 16():63. PubMed ID: 26493839
[TBL] [Abstract][Full Text] [Related]
15. Predictor for the effect of amino acid composition on CD4+ T cell epitopes preprocessing.
Hoze E; Tsaban L; Maman Y; Louzoun Y
J Immunol Methods; 2013 May; 391(1-2):163-73. PubMed ID: 23481624
[TBL] [Abstract][Full Text] [Related]
16. Antigen-specific immunomodulation for type 1 diabetes by novel recombinant antibodies directed against diabetes-associates auto-reactive T cell epitope.
Dahan R; Gebe JA; Preisinger A; James EA; Tendler M; Nepom GT; Reiter Y
J Autoimmun; 2013 Dec; 47():83-93. PubMed ID: 24090977
[TBL] [Abstract][Full Text] [Related]
17. Recognition of core and flanking amino acids of MHC class II-bound peptides by the T cell receptor.
Sant'Angelo DB; Robinson E; Janeway CA; Denzin LK
Eur J Immunol; 2002 Sep; 32(9):2510-20. PubMed ID: 12207335
[TBL] [Abstract][Full Text] [Related]
18. A population response analysis approach to assign class II HLA-epitope restrictions.
Paul S; Dillon MBC; Arlehamn CSL; Huang H; Davis MM; McKinney DM; Scriba TJ; Sidney J; Peters B; Sette A
J Immunol; 2015 Jun; 194(12):6164-6176. PubMed ID: 25948811
[TBL] [Abstract][Full Text] [Related]
19. Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation.
Wälchli S; Kumari S; Fallang LE; Sand KM; Yang W; Landsverk OJ; Bakke O; Olweus J; Gregers TF
Eur J Immunol; 2014 Mar; 44(3):774-84. PubMed ID: 24293164
[TBL] [Abstract][Full Text] [Related]
20. Antigen discovery and specification of immunodominance hierarchies for MHCII-restricted epitopes.
Graham DB; Luo C; O'Connell DJ; Lefkovith A; Brown EM; Yassour M; Varma M; Abelin JG; Conway KL; Jasso GJ; Matar CG; Carr SA; Xavier RJ
Nat Med; 2018 Nov; 24(11):1762-1772. PubMed ID: 30349087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]